Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Matrine
Cat. No.:
OB0225LY-0325
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Matrine is an alkaloid extracted from Sophora genus with anti-inflammatory, anti-tumor and immunomodulatory properties.
Synonym:
Vegard; Matridin-15-one; Matrinium; α-Matrine; (+)-Matrine; 519-02-8
CAS No.:
519-02-8
Compound CID:
91466
Formula:
C15H24N2O
Formula Weight:
248.36
Specification
Source:
Sophora genus
Relative Density:
1.16 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Matrine can be used for pharmacological studies.
Library Information
Targets:
G protein-coupled receptors
Receptors:
Opioid receptor; κ-Opioid receptor
Pathways:
Endocrinology/Hormones; GPCR/G protein; Neuronal signaling; Autophagy; Apoptosis
Plate Number:
AOCL-5
Plate Location:
b9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 181.18 mM
Water Max Solubility:
11 mg/mL; 44.29 mM
Ethanol Max Solubility:
49 mg/mL; 197.29 mM
